Predictor | OR (95% CI) |
---|---|
Univariate analysis | |
Age | 0.99 (0.96–1.02) |
Gender | 1.59 (0.69–3.67) |
Symptom duration > 24 wk | 0.77 (0.33–1.76) |
Weight loss > 30 lbs (13.6 kg) | 2.98 (0.92–9.61) |
Tumour location other than GEJ | 0.75 (0.33–1.77) |
High-grade tumour | 1.68 (0.32–8.89) |
Signet cell subtype | 1.98 (0.87–4.52) |
Tumour visible on staging CT | 9.75 (1.24–76.50) |
Abdominal lymphadenopathy > 1 cm | 2.38 (1.06–5.35) |
Ascites | 19.1 (2.24–161.80) |
Omental nodules | 4.65 (0.41–53.00) |
Multivariate analysis | |
Weight loss > 30 lbs (13.6 kg) | 3.52 (0.95–12.32) |
Tumour visible on staging CT | 8.44 (1.04–68.26) |
Ascites | 15.86 (1.84–137.02) |
CI = confidence interval; CT = computed tomography; GEJ = gastroesophageal junction; OR = odds ratio.